Elevation Oncology Inc (ELEV)
3.695
-0.12
(-3.27%)
USD |
NASDAQ |
May 03, 16:00
3.695
0.00 (0.00%)
After-Hours: 20:00
Elevation Oncology 1 Year Total Returns (Daily): 16.82% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 16.82% |
| May 01, 2024 | 30.72% |
| April 30, 2024 | 34.98% |
| April 29, 2024 | 46.39% |
| April 26, 2024 | 19.47% |
| April 25, 2024 | 113.2% |
| April 24, 2024 | 110.9% |
| April 23, 2024 | 136.1% |
| April 22, 2024 | 121.3% |
| April 19, 2024 | 93.88% |
| April 18, 2024 | 109.9% |
| April 17, 2024 | 113.4% |
| April 16, 2024 | 125.1% |
| April 15, 2024 | 127.2% |
| April 12, 2024 | 148.9% |
| April 11, 2024 | 141.0% |
| April 10, 2024 | 130.0% |
| April 09, 2024 | 135.5% |
| April 08, 2024 | 132.0% |
| April 05, 2024 | 161.2% |
| April 04, 2024 | 166.3% |
| April 03, 2024 | 173.5% |
| April 02, 2024 | 170.0% |
| April 01, 2024 | 162.6% |
| March 28, 2024 | 170.0% |
| Date | Value |
|---|---|
| March 27, 2024 | 151.8% |
| March 26, 2024 | 132.6% |
| March 25, 2024 | 113.0% |
| March 22, 2024 | 118.4% |
| March 21, 2024 | 114.8% |
| March 20, 2024 | 106.7% |
| March 19, 2024 | 72.55% |
| March 18, 2024 | 70.98% |
| March 15, 2024 | 89.22% |
| March 14, 2024 | 176.9% |
| March 13, 2024 | 275.7% |
| March 12, 2024 | 240.0% |
| March 11, 2024 | 265.8% |
| March 08, 2024 | 243.6% |
| March 07, 2024 | 233.3% |
| March 06, 2024 | 236.0% |
| March 05, 2024 | 309.6% |
| March 04, 2024 | 321.9% |
| March 01, 2024 | 310.7% |
| February 29, 2024 | 300.0% |
| February 28, 2024 | 249.2% |
| February 27, 2024 | 236.9% |
| February 26, 2024 | 141.7% |
| February 23, 2024 | 103.2% |
| February 22, 2024 | 172.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.37%
Minimum
Jul 12 2022
321.9%
Maximum
Mar 04 2024
-13.79%
Average
-43.07%
Median
1 Year Total Returns (Daily) Benchmarks
| Merrimack Pharmaceuticals Inc | 17.51% |
| Mersana Therapeutics Inc | -23.06% |
| Equillium Inc | 176.2% |
| Monopar Therapeutics Inc | -31.26% |
| Larimar Therapeutics Inc | 67.25% |